



The pharmacological effects of alcohol on executive function, craving and subsequent 
alcohol-seeking have been well-documented. Yet, insufficient methodological controls within 
existing alcohol administration paradigms have meant that the relative importance of 
alcohol’s pharmacological and anticipatory effects remain in need of further elucidation.  
Aims:  
To disentangle alcohol’s pharmacological from its anticipatory effects on alcohol-related 
cognitions and subsequent consumption. 
Methods:   
Inhibitory control, attentional bias and craving were assessed pre- and post-consumption in 
100 participants who were randomly allocated to one of four beverage conditions in a two by 
two design: (i) alcohol aware (alcohol with participant knowledge 
[pharmacological/anticipation effects]) (ii) alcohol blind (alcohol without participant 
knowledge; in a novel grain alcohol masking condition [pharmacological/no anticipation 
effects]) (iii) placebo (no alcohol but participants were deceived [anticipation/non-
pharmacological effects]) and (iv) pure control (no alcohol with participant knowledge [no 
anticipation/non-pharmacological effects]).  
Results:  
Findings suggest that the pharmacological effects of alcohol result in greater inhibitory 
control impairments compared with anticipated effects. Anticipatory but not the 
pharmacological effects of alcohol were found to increase attentional bias. Both 
pharmacology and anticipation resulted in increased craving, though higher levels of craving 
were observed due to alcohol’s pharmacology. Furthermore, alcohol pharmacology resulted 
in heightened ad libitum consumption, however, anticipation did not. Changes in craving 
partially mediated the relationship between initial intoxication and subsequent drinking, 
while inhibitory control impairments did not.  
Conclusions: 
Successive alcohol consumption appears driven primarily by the pharmacological effects of 





Research has established that both the pharmacological effects of intoxication and the 
psychologically anticipated effects of alcohol consumption impact alcohol behaviours in 
important ways.  For example, low doses of alcohol have been found to increase subsequent 
consumption (Fernie et al., 2012), possibly by impairing inhibitory control mechanisms 
(Weafer & Fillmore, 2016) or by eliciting craving (McNeill et al., 2021).  It is also 
established that psychosocially negotiated expectations about one’s own and others’ alcohol 
behaviours (McAndrew & Edgerton, 1969) and related cognitions (Marlatt et al., 1973) can 
exert significant influences on alcohol behaviours (Christiansen et al., 2017).  To date, 
however, it has not been possible to fully disentangle alcohol’s pharmacological and 
anticipated effects. This is because existing paradigms necessitate that participants either 
experience anticipation (in placebo conditions where non-alcoholic drinks are made to appear 
alcoholic) or pharmacological effects of alcohol combined with anticipation (in conditions 
where participants are given alcohol to drink). In other words, to date it has not been possible 
to assess the pharmacological effects of alcohol without also, to a greater or lesser degree, 
eliciting anticipatory effects. In order to achieve intoxication without anticipation, the current 
study addresses this limitation by introducing a methodology where beverages are also 
administered in a novel experimental condition in which participants are deceived about their 
alcoholic contents. 
 
Existing research on how alcohol pharmacology impacts cognitive processing and 
consumption behaviour has primarily used a placebo alcohol condition as the basis for 
comparing the relative effects of intoxication. Here effects are assessed between participants 
who knowingly receive alcohol and those in the placebo group, who falsely believe their 
drinks contain alcohol. This approach has illuminated how alcohol affects various cognitive 
processes including impairing inhibitory control (e.g., Caswell et al., 2013; Weafer & 
Fillmore, 2008), dose dependent effects on attentional bias (e.g., Duka & Townshend, 2004; 
Weafer & Fillmore, 2013), heightened craving (e.g., Rose & Grunsell, 2008) and increased 
risk taking (e.g., Rose et al., 2014). 
 
The effects of alcohol pharmacology on cognitive processes have therefore been well 
documented, and the resulting transient changes have been found to be associated with 
subsequent alcohol consumption (Field et al., 2010). Specifically, consuming alcohol 
(sometimes referred to in the literature as alcohol pre-load, or ‘priming’ conditions), appears 
to be associated with increased alcohol seeking behaviours (including consumption; de Wit, 
1996) and it has been suggested that these changes in behaviour are mediated by transient 
impairments in inhibitory control (Field et al., 2010). This theoretical view is informed by 
Weafer and Fillmore’s (2008) work indicating that ad libitum consumption in a follow-up 
session correlated with alcohol induced inhibitory control impairments. While this research 
points to important relationship facets between inhibitory control changes and consumption, 
owing to its correlational nature, it was not designed to examine this relationship causally. 
Attempts to establish a causal link between inhibitory control and consumption by 
administering Transcranial Magnetic Stimulation to the right Dorsolateral Prefrontal Cortex 
(rDLPFC) have yielded mixed findings and highlight the possibility that other mechanisms 
may underpin this relationship (McNeill et al., 2018).  
 
Alcohol-related attentional bias, identified as a further potential driver of consumption 
(Field & Cox, 2008), has also generated inconsistent findings. On the one hand, a 
bidirectional association between heightened attentional bias and alcohol-seeking behaviours 
has garnered support (ibid), and recent studies indicate that alcohol-related attentional bias is 
most pronounced immediately prior to a drinking (Spanakis et al., 2019). However, the acute 
effects of alcohol on attentional bias also appear to be affected by peoples’ previous alcohol 
involvement and acute intoxication. For instance, one study found that dose increases were 
associated with attentional bias decreases in heavy social drinkers but not among moderate 
social drinkers (Weafer & Fillmore, 2013). On the other hand, Fernie and colleagues (2012) 
found no effect of low doses of alcohol on attentional bias in heavy social drinkers, but an 
increase in light social drinkers. In both of these studies, changes in attentional bias were 
unrelated to ad libitum consumption. The existing literature therefore points to an intricate 
relationship between initial alcohol consumption and attentional bias, and further research to 
unpick the relative contributions of alcohol pharmacology and anticipation is required.   
 
Theoretically it has been proposed that alcohol anticipation is driven by the associated 
reinforcing effects of its pharmacology (Marlatt et al., 1973) in that alcohol initiates a 
‘priming’ effect, triggering alcohol seeking behaviours and eliciting cognitive changes which, 
to a greater or lesser extent, are comparable to those of alcohol itself (ibid). Complimenting 
cognitive approaches, McAndrews and Edgerton (1969) suggest theoretically that alcohol-
associated environments and beliefs about normative alcohol behaviours can induce similar 
changes in alcohol seeking behaviour. Both cognitive and social research and theoretical 
contributions therefore converge to suggest that the mere suggestion of alcohol, whether that 
be smell of alcohol (e.g., Monk et al., 2016) or alcohol-related contexts (e.g., Field & Jones, 
2017), can induce both cognitive and behavioural changes akin to actual alcohol 
consumption.  
 
Overall, significant attempts have been made to understand the contributions of 
alcohol anticipation on inhibitory control and attentional bias, with the inclusion of pure 
control conditions where participants are administered a beverage free of alcohol and 
informed of this (e.g., Christiansen et al., 2013), with resultant performance of these 
participants compared against those in placebo and alcohol aware conditions (i.e.. the pp 
knowingly consume alcohol prior to testing). These studies have found the effects of 
anticipation on inhibitory control and craving to be relatively consistent. Specifically, they 
indicate that placebo-alcohol produces inhibitory control impairments (which are indicative 
of expectancy effects), while these impairments are not comparable with those evident in 
intoxicated participants in the alcohol aware condition (e.g., Christiansen et al., 2016). 
Similarly, there is evidence to suggest that placebo alcohol also heightens craving 
(Christiansen et al., 2013; Christiansen et al., 2016), but that patterns of craving differ in 
alcohol aware and placebo conditions (Rose et al., 2013). However, the literature evidencing 
the relationship between anticipation and attentional bias is scant, with one study 
demonstrating a heightening of attentional bias following placebo in heavy drinkers (Weafer 
& Fillmore, 2013). Furthermore, findings supporting the assertion that anticipation provokes 
increases in seeking behaviour are inconsistent (e.g., Christensen et al., 2017; Christiansen et 
al., 2013). So, while the inclusion of pure control designs has illuminated the relative 
contribution of anticipation to alcohol-related cognitions, findings have remained mixed and 
study designs have not been able to fully extricate the impact of anticipation from that of 
pharmacology.  
 
To this end, the current study sought to build on the growing body of literature in this 
domain, by administering an alcohol blind condition. Here, researchers covertly dispensed 
alcohol within provided beverages, while participants were informed they are in a control 
condition and that their drink is free from alcohol. By introducing this protocol alongside a 
traditional alcohol aware, placebo and pure control administration protocols, it aimed to tease 
apart the relative influence of pharmacology and anticipation exert on alcohol-related 
cognitions and consumption. Specifically, a 2 x 2 between participants design was employed 
with independent variables of anticipation (anticipation vs no anticipation) and pharmacology 
(pharmacological vs non-pharmacological) to test the following hypotheses:   
1. Both the anticipatory effects of alcohol (present in the placebo condition) and 
alcohol’s pharmacology (present in the alcohol aware and alcohol blind conditions) 
will result in i) impaired inhibitory control and ii) heightened craving.  
2. The pharmacological effects of alcohol (in the alcohol aware and alcohol blind 
conditions) will result in significantly greater i) impairments in inhibitory control and 
ii) increases in craving. 
3. Alcohol-related attentional bias will be significantly more pronounced in alcohol 
anticipation (in the placebo condition) rather than pharmacology conditions (in the 
alcohol aware and alcohol blind conditions). 
4. Ad libitum consumption will be increased by alcohol’s pharmacological effects (in the 
alcohol aware and alcohol blind conditions). 
5. These patterns of ad libitum consumption will be mediated by i) inhibitory control 






One hundred (57 female) participants aged 18 to 49 (M = 21.18, SD = 4.73) who were fluent 
English speakers and whose weekly consumption regularly exceeded the recommended limit 
of 14 UK units were recruited. Participants were from the student and staff populations of a 
University in Northwest England. They completed a medical screen questionnaire and 
participants indicating that they had medical conditions or were taking medications known to 
interact with alcohol were excluded from the study. Those with a personal or family history 
of Alcohol Use Disorder were also excluded. Participants were reimbursed for their time by 
way of course credit or £10. The study was given ethical scrutiny and approval by the Faculty 
of Arts and Sciences Research Ethics Committee, Edge Hill University.  
Design 
 
A randomised 2 x 2 between participants design was implemented, with independent 
variables of: anticipation (anticipation vs no anticipation) and pharmacology 
(pharmacological vs non-pharmacological). This was assessed using four beverage 
conditions: alcohol aware (pharmacology with anticipation), alcohol blind (pharmacology 
without anticipation), placebo (anticipation without pharmacology) and pure control (neither 
anticipation or pharmacology).  Measures of inhibitory control, attentional bias and craving 
were taken both pre- and post-beverage administration, followed by a measure of ad libitum 
alcohol consumption. Dependent variables were computed by subtracting pre-beverage 
scores from post-beverage scores on each of the measures to produce a change score.   
Materials 
 
TimeLine Followback (TLFB: Sobell & Sobell, 1990). Participants retrospectively self-report 
their alcohol consumption (in units) for the previous 14 days. Requiring participants to 
provide the number of units of alcohol consumed each day. 
  
The Alcohol Use Disorders Identification Test (AUDIT: Saunders et al., 1993). The AUDIT 
consists of 10 items regarding alcohol consumption and its consequences. Scores range from 
0-40, with scores ≥ 8 representative alcohol consumption of a hazardous level. This was 
shown to be reliable in the current sample (α = .77). 
  
Barratt Impulsivity Scale (BIS-11: Patton et al., 1995). The BIS is a multidimensional scale, 
consisting of three subscales; attentional, motor and non-planning impulsiveness. BIS-11 
includes thirty fixed response items (e.g., ‘I plan tasks carefully’), each on a four point scale 
(rarely/never – almost always/always); higher scores are indicative of increased impulsivity. 
The scale was found to be reliable in the current sample (α = .81).   
  
Desire for Alcohol Questionnaire – brief form (DAQ; Love et al., 1998). The DAQ is a 14-
item four-dimensional alcohol craving questionnaire. The factors include; positive and 
negative reinforcement, strong desires and intentions, and mild desires and intentions. The 
scale is scored on 1-7 Likert scale, with higher scores indicative of higher craving. Reliability 
analysis revealed the DAQ to be reliable in study 2 both pre (α = .78) and post (α = .80) 
beverage administration, both showing acceptable internal reliability.   
 
Mood and Subjective Intoxication Scales. The scales consisted of 10 statements to which 
participants responded on a 100mm Visual Analogue Scale ranging from ‘Not at all’ to 
‘Extremely’. A total of six mood statements (e.g., ‘I feel happy, I feel sad’), 3 each for 
positive and negative moods and 4 intoxication statements (e.g., ‘I feel drunk, I feel dizzy’).  
 
Computerised cognitive tasks 
Stop-signal task (SST: Verbruggen et al., 2008). The Stop Signal task consists of two 
concurrent tasks: A Go task (75% of trials), which is a choice reaction task where participants 
categorise arrows on the screen based on their orientation (left or right) and a stop task (25% 
of trials) where an auditory tone (the stop signal) indicates that participants should inhibit 
their response to the go signal. Participants are required to respond as quickly and accurately 
as possible to the stimuli with a predetermined corresponding key. Upon hearing the auditory 
tone (the stop signal) participants are required to inhibit their response. After 2000ms the trial 
times out.   
  
On the stop trials, tones are delivered at fixed delays (known as Stop-signal delays or 
SSD) of between 50ms and 500ms following the presentation of the go stimulus. The stop 
signal task uses these SSDs dynamically, based on participant performance. The one-up one-
down tracking procedure (Logan et al., 1997) was implemented, which adjusts the SSDs after 
each trial. After successful inhibition trials, the SSD increases by 50ms, handicapping the 
stop signal process on the next stop signal trial. Unsuccessful inhibition trials result in the 
SSD decreasing by 50ms. In accordance with the ‘horse race’ model, the degree of difficulty 
in inhibiting responding increases as the delay between the go stimulus and the stop signal 
increases (Logan et al., 1984). The task provides an outcome variable of stop-signal reaction 
time (SSRT). SSRT is calculated by extracting the percentage errors (failure to inhibit 
response on stop trials) at each of the SSDs (50 – 500ms, at 50ms intervals), then calculating 
a SSRT value for each SSD based on the reaction time (RT) distribution. Overall SSRT score 
was calculated by averaging the SSRT values for each of the SSD’s. Impaired response 
inhibition is demonstrated through longer SSRT values; SSRT represents an estimate of the 
time required to stop initiated Go response (see Band et al., 2003). Participants received 3 
experimental blocks of 64 trials, allowing for a short break between each block. Internal 
reliability was assessed between each of the 3 experimental blocks for both pre- and post-
manipulation (pre α = .77, post α = .71) both indicating acceptable reliability.  
 
Visual Probe task (Schoenmakers, Wiers & Field, 2008). The visual probe task was 
programmed in Experiment Builder and deployed in concurrence with the Eye-link 1000 eye-
tracker (SR Research, Mississauga, ON, Canada) to assess attentional-bias. The task begins 
with the presentation of a fixation cross, signalling the beginning of each trial. Following this, 
manual submission of any key triggers the exhibition of images which are presented side-by-
side 60mm apart, in alcohol/neutral pairs. Each trail had a duration of 2000ms and the task 
consisted of 40 trials in total. During each trail participants were instructed to allow their 
attention to drift over the images naturally, but they do not need to manually respond to the 
pictures. The pictorial stimuli consisted of ten alcohol-related pictures (as used by 
Christiansen et al., 2013) were matched with ten control pictures, based on brightness, 
complexity and valence. The alcohol-related pictures portrayed alcohol (e.g., bottle of beer, 
wine or spirits) or alcohol being consumed. The neutral pictures portrayed stationary (e.g., 
pens) or close-up action shots of stationary in use (e.g., a person licking an envelope). 
Pictures were each presented four times in pseudorandom order, twice on the right and twice 
on the left. Alcohol-related images (e.g., beer bottle) were always paired with stationary only 
images (e.g., pens), while images of alcohol being consumed were paired with action shots of 
stationary in use. Pictures were presented in landscape (125mm wide x 100mm high). Dwell 
time was calculated by summing the time (ms) participants spent focusing on both the 
alcohol and neutral stimuli for each trail, with a subsequent mean for alcohol and neutral 
stimuli calculated. The reliability of the Visual Probe task was shown to be fairly poor, both 
pre (α = .53) and post (α = .36), however, this is consistent with previous findings (e.g., Field 
& Christiansen, 2012).  
Alcohol Administration  
 
All drinks were divided into 3 equal glasses and the participants were given 10 minutes to 
consume the total volume of the presented mixtures, followed by a 20 minutes rest period 
prior to completing post-consumption experimental tasks. 
 
Alcohol aware and placebo conditions  
The administration of an alcohol here is to assess its acute pharmacological effects. 
As per Rose and Grunsell (2008), participants were administered a volume of alcohol based 
on their weight (.4g/kg). In the alcohol aware condition, alcohol in the form of vodka was 
mixed with fresh orange juice and tonic water in equal parts. It was made clear to participants 
the beverage contained alcohol. In the placebo condition, participants were administered 
equal parts fresh orange juice and tonic water, which has a natural bitterness to heighten the 
sense of alcohol’s presence. To enhance the illusion of alcohol consumption, vodka (>2ml) 
was sprayed lightly on the rim of the glass and participants were told their drink contained 
alcohol. Overall, the placebo condition is designed to present a non-alcoholic drink as a drink 
containing alcohol using deception.  
Alcohol blind condition  
For the alcohol blind condition, grain ethanol (.4g/kg) was mixed with orange juice, 
calculated to match the dilution of the alcohol aware condition mixture. Grain ethanol was 
opted for over vodka as a significantly lower volume of liquid is required to meet the .4g/kg. 
This increased the possibility of masking the presence of alcohol. Ten millilitres of liquid 
sweetener (Canderel®) were added to the mixture to further mask the bitterness of the 
ethanol (informed by pilot testing) and participants were asked to consume a strong mint 
immediately prior to drinking as a further concealment. Unlike the other beverage conditions 
(alcohol aware, placebo), the alcohol blind beverage did not contain tonic water, due the 
natural bitterness associated, thus, mitigating the use of sweetener. Participants were 
informed that they were in a control condition and that their beverages had been prepared to 
match the calorific content of drinks in the alcohol condition.  
Pure control condition  
 For the pure control condition, participants were given fresh orange juice (tonic was 
not used as its bitterness may inappropriately suggest the presence of alcohol) of volume 
equivalent to other conditions and based on their body mass, and the participants were 
informed the drink contained no alcohol.  They were also presented the drink in 3 equal 
measures and had 10 minutes to consume, followed by the same 20-minute rest period. 
Ad libitum consumption 
Ad libitum consumption is a method of measuring immediate alcohol consumption, indicative 
of motivation to drink, following an experimental manipulation (e.g., the administration of an 
alcohol pre-load). The bogus taste test is a means of assessing ad libitum alcohol 
consumption while reducing participant demand characteristics, using deception 
(Christiansen et al., 2015). Participants were presented with three different beers (330ml of 
each) and asked to rate the taste of each beer on ten dimensions (e.g., pleasant and light; see 
Jones et al., 2011). For rating purposes, participants were informed that they may drink as 
little or as much as they need. The remaining volume was then measured and subtracted from 
the initial volume to indicate how much the participant consumed.   
 
Procedure 
Each experimental session took place between 12-6pm in a laboratory. Participants were 
informed that they were required to refrain from drinking alcohol a minimum 12 hours prior 
and upon arriving at the laboratory a breathalyser reading was taken in order to ensure a 
reading of .00mg/l (Lion Alcolmeter 400, Lion Laboratories, Vale of Glamorgan, United 
Kingdom). Participants were also asked to avoid eating 3 hours before the session. After 
providing informed consent, participants completed an initial questionnaire battery (TLFB, 
AUDIT, BIS, DAQ, mood and intoxication scales), followed by baseline measures of 
inhibitory control and attentional bias, in a counterbalanced order. Participants were then 
provided with a beverage, dependent on their randomly allocated beverage condition (n = 25 
per condition). They were informed they had 10 minutes to drink the whole drink and they 
were then given a 20-minute rest period. Participants were then breathalysed for a second 
time, before repeating the DAQ, mood and subjective intoxication scales, measures of 
inhibitory control and attentional bias, all in a counterbalanced order. Finally, participants 
completed the bogus taste task to measure their ad libitum consumption. Experimental 
sessions took approximately 1 hour 40 minutes and all participants were fully debriefed 






A MANOVA was performed to assess any differences between conditions or genders in 
terms of sample characteristics (e.g., AUDIT, BIS). No significant differences were revealed 
between conditions Pillai’s Trace = .20, F(18, 279) = 1.30, p = .32, ηp
2= .07 or between 
genders Pillai’s Trace = .09, F(6, 93) = 1.61, p = .15, ηp
2= .09. A further ANOVA was 
performed to ensure that there were no difference between genders for breath alcohol level 
post beverage (only alcohol containing conditions assessed), F(1, 48) = .20, p = .66, ηp
2= 
.004. Table 1 contains means and standard deviations for all baseline measures.  
 
Table 1: Means (and standard deviations) for sample characteristics, broken down by gender 
and beverage condition 
 Male    
(n = 43) 
Female 
(n = 57) 
Pure 
Control 
(n = 25) 
Placebo 
(n = 25) 
Alcohol 
Blind   
(n = 25) 
Alcohol 
Aware   
(n = 25) 
Total    

























































































AUDIT = Alcohol Use Disorder Identification Test, TLFB = Timeline Followback a measure of UK units 
consumed over the past 14 days, BIS = Barrett Impulsivity Scale and Attentional, Motor and Non-planning are 




A MANOVA was undertaken to assess if any differences existed between conditions for pre-
beverage scores, no significant effect of beverage condition was observed Pillai’s Trace = 
.09, F(15, 282) = .56, p = .91, ηp
2= .03. Subsequently, pre-beverage scores were subtracted 
from the post-beverage score to produce change scores. Table 2 contains means and standard 
deviations for pre- and post-beverage, plus change scores for positive and negative mood, and 









Table 2: Mean and standard deviations for pre- and post-beverage dependent variable 
scores, and change scores 
 Pure Control 
(n = 25) 
Placebo 
(n = 25) 
Alcohol Blind   
(n = 25) 
Alcohol Aware   
(n = 25) 
 Mean (SD) Mean (SD) Mean (SD) Mean (SD) 
Pre-positive  214.56 (45.89) 203.36 (37.08) 203.60 (42.37) 205.80 (42.58) 
Post-positive 216.64 (49.79) 207.12 (32.47) 209.68 (41.53) 210.20 (42.88) 
Positive change 2.08 (15.50) 3.76 (20.32) 6.08 (17.94) 4.40 (18.32) 
Pre-negative 62.20 (35.49) 78.20 (28.07) 72.84 (30.50) 79.68 (38.00) 
Post-negative 80.37 (40.72) 74.88 (23.83) 75.48 (32.24) 76.60 (36.06) 
Negative change 18.16 (23.48) -3.32 (13.28) 2.64 (18.75) -3.08 (17.54) 
Pre-SSRT 196.81 (40.36) 184.33 (41.13) 189.85 (64.63) 201.35 (65.64) 
Post-SSRT 197.43 (35.83) 247.30 (39.52) 282.21 (55.57) 284.90 (60.07) 
SSRT Change .62 (38.79) 62.98 (52.83) 92.36 (59.69) 83.55 (60.06) 
Pre-AB 120.06 (137.60) 125.11 (143.14) 124.98 (163.64) 166.28 (176.89) 
Post-AB 145.87 (112.86) 294.05 (134.04) 142.97 (117.08) 145.54 (228.19) 
AB Change 25.81 (115.38) 168.94 (155.80) 18.00 (232.14) -20.72 (302.54) 
Pre-DAQ 38.60 (10.07) 38.68 (7.08) 38.92 (7.10) 38.61 (6.70) 
Post-DAQ 37.96 (11.44) 46.84 (10.13) 49.52 (11.34) 54.68 (8.84) 
DAQ Change .64 (5.79) 8.16 (9.04) 10.60 (9.20) 16.32 (6.85) 
Positive/Negative = mood state, SSRT = Stop-Signal Reaction Time, AB = alcohol-related attentional bias, 
DAQ = Desires for Alcohol Questionnaire. Change scores were calculated by subtracting pre- from post-
beverage scores.  
 
Mood and subjective intoxication  
Two 2 (anticipation vs no anticipation) x 2 (pharmacological vs non-pharmacological) 
ANCOVAs were employed to assess changes in mood controlling for AUDIT, one for 
positive and one for negative mood. For positive mood scores, there was no main effect of 
anticipation F(1, 95) = .00, p > .999, ηp
2 = .00 or pharmacology F(1,95) = .41, p = .52, ηp
2 
=.004. Nor was there a significant interaction F(1,95) = .22, p = .64, ηp
2 =.002. There were, 
however, significant main effects observed for changes in negative mood. Specifically, scores 
were significantly lower in the anticipation conditions (i.e., placebo and alcohol aware) 
compared with the no anticipation conditions (i.e., pure control and alcohol blind) F(1, 95) = 
13.14, p < .001, ηp
2 =.12, and lower in the pharmacological (i.e., alcohol aware and alcohol 
blind)  compared with the non-pharmacological conditions (i.e., pure control and placebo) 
F(1, 95) = 4.12, p = .045, ηp
2 = .04. There was also a significant interaction between 
anticipation and pharmacology F(1, 95) = 4.33, p = .04, ηp
2 = .05, with Bonferroni corrected 
pairwise comparisons indicating that the non-anticipatory and non-pharmacological condition 
(i.e., pure control) showed significantly higher negative mood scores compared with the non-
anticipatory and non-pharmacological condition (alcohol blind) (p = .004, d = .75). See 
figure 1 for means and standard errors.  
 
Figure 1: Mean and standard errors bars for negative mood state change for both anticipation and 
pharmacological conditions.  
 
 
A 2 (anticipation vs no anticipation) x 2 (pharmacological vs non-pharmacological) 
ANCOVA was employed to assess changes in subjective intoxication. There was a 
significant effect of anticipation on subjective intoxication F(1, 95) = 39.91, p < .001, ηp
2 = 
.30, with subjective intoxication higher in the anticipation condition (i.e., placebo and alcohol 
aware). Also, a significant effect of pharmacology was observed on subjective intoxication 
F(1, 95) = 51.34, p < .001, ηp
2 = .35. Specifically, subjective intoxication was higher for 
pharmacological conditions (i.e., alcohol aware and alcohol blind). There was also a 
significant anticipation x pharmacology interaction F(1, 95) = 4.18, p = .04, ηp
2 = .04. 
Bonferroni pairwise comparisons indicating that for both non-pharmacological (i.e., placebo; 
p < .001, d = 1.94) and pharmacological conditions (i.e., alcohol aware; p = .003, d = .79), 
anticipation resulted in higher ratings of intoxication than where there was no anticipation of 
alcohol. See figure 2 for means and standard errors.  
 
 
Figure 2: Mean and standard errors for subjective intoxication for both anticipation and 
pharmacological conditions.  
 
Inhibitory control 
A 2 (anticipation vs no anticipation) x 2 (pharmacological vs non-pharmacological) 
ANCOVA were utilised to examine changes in stop-signal reaction time (SSRT), controlling 
for AUDIT and trait impulsivity (BIS-11). There was a significant main effect of anticipation 
F(1,94) = 6.16, p = .015, ηp
2 = .06, demonstrating that where there was anticipation of alcohol 
(i.e., plaebo and alcohol aware) there were greater impairments in inhibitory control 
compared to conditions where  there was no anticipation (i.e., pure control and alcohol blind). 
There was also a main effect of pharmacology F(1, 94) = 21.43, p < .001, ηp





p < .001, 
d = 1.94
p = .003, 
d = .79p < .001, 
d = .96
pharmacological conditions resulting in greater inhibitory control impairments. These main 
effects were qualified by a significant anticipation x pharmacology interaction was observed 
F(1, 94) = 9.86, p = .002, ηp
2 = .10, with Bonferroni corrected pairwise comparisons 
revealing significantly more impaired inhibitory control in non-pharmacological conditions 
with anticipation (placebo) versus where there was no anticipation (pure control) (p < .001, d 
= 1.37), but no significant difference between anticipation (in the alcohol aware condition) 
and no anticipation (the alcohol blind condition) for pharmacological conditions (p = .56, d = 
.15). See figure 3 for means and standard errors.  
 
Figure 3:  Means and standard errors for stop-signal reaction time (SSRT) for both anticipation and 
pharmacological conditions  
 
Attentional Bias 
A 2 (anticipation vs no anticipation) x 2 (pharmacological vs non-pharmacological) 
ANCOVA examined changes in alcohol-related attentional bias (AB), controlling for AUDIT 
and BIS-11. The effect of anticipation was non-significant F(1, 94) = 1.56, p = .21, ηp
2 = .02. 
There was however, a significant main effect of pharmacology F(1, 94) = 5.33, p < .025, ηp
2 
= .05, with alcohol-related AB significantly higher in the non-pharmacological conditions. 
There was also a significant anticipation x pharmacology interaction F(1, 96) = 4.31, p = .04, 
ηp
2 = .04. Bonferroni pairwise comparisons revealed that within non-pharmacological 
conditions, AB was significantly elevated where there was anticipation of alcohol (in the 
placebo condition) rather than where there was no anticipation (the pure control condition) (p 
= .015, d = 1.07). In pharmacological conditions, there was no difference in AB irrespective 
of anticipation (p = .48, d = .15). See figure 4 for means and standard errors1.  
 
 
Figure 4: Means and standard errors for alcohol-related attentional bias (AB) for both anticipation 
and pharmacological conditions. (NB: Positive AB change scores indicate greater dwell time on 
alcohol-related images compared to neutral)   
 
Craving 
A 2 (anticipation vs no anticipation) x 2 (pharmacological vs non-pharmacological) 
ANCOVA were utilised to assess craving change, controlling for AUDIT. The was a 
significant main effect of anticipation F(1, 95) = 21.05, p < .001, ηp
2 = .18, demonstrating 
                                                     
1 Positive AB values are indicative of greater dwell time on alcohol-related images compared with neutral 
images.  
elevated craving associated with anticipation (i.e., placebo and alcohol aware) There was also 
a significant main effect of pharmacology F(1, 95) = 35.26, p < .001, ηp
2 = .27, with 
pharmacological conditions showing higher craving (alcohol aware and alcohol blind). There 
was however, no significant anticipation x pharmacology interaction F(1, 95) = .91, p = .34, 
ηp
2 .01. See figure 5 for means and standard errors.  
 
Figure 5: Means and standard errors for Desires for Alcohol (DAQ; craving) for both anticipated and 
pharmacology conditions.  
 
Supplementary correlation analysis was undertaken to examine the relationship between 
attentional bias and craving. Overall, there was no correlation evident r = .09, p = .35. When 
analysed by condition however, a significant correlation was seen for anticipation/non-
pharmacological (placebo) r = .48, p < .025, but not for any other conditions (p’s > .29).  
 
Ad libitum consumption 
A 2 (anticipation vs no anticipation) x 2 (pharmacological vs non-pharmacological) 






p < .001, 
d = 1.19
consumption, controlling for AUDIT and BIS-11. There was no main effect of anticipation 
F(1, 94) = 1.24, p = .27, ηp
2 = .01, but there was a significant effect of pharmacology F(1, 94) 
= 21.00, p < .001, ηp
2 = .18. Specifically, pharmacological conditions resulted in higher ad 
libitum consumption. There was no anticipation x pharmacology interaction found F(1, 94) = 
.05, p = .82, ηp
2 = .00. See figure 6 for means and standard errors.  
  
Figure 6: Means and standard errors for ad libitum consumption for both anticipated and 
pharmacology conditions.  
 
Mediation 
All Mediation analyses were undertaken using the PROCESS 3.4 macro for SPSS. First, to 
assess if SSRT change mediate the relationship between initial intoxication and subsequent 
consumption, the SSRT change score was calculated by subtracting the pre-beverage SSRT 
from post-beverage SSRT. This new variable was then used as the mediator in the analysis. 
Using the multicategorical function, dummy variables were formed, comparing each 
condition to control (X1 = placebo vs pure control, X2 = alcohol blind vs pure control, X3 = 
alcohol aware vs pure control). There was a significant direct effect (c path) of alcohol 
present conditions on ad libitum consumption, X2 t(96) = 3.39, p < .01, 95%CI [78.10, 
299.02], X3 t(96) = 4.34, p < .001, 95%CI [130.82, 351.74], however, the placebo condition 
did not show elevated consumption X1 t(96) = .65, p = .52, 95%CI [-74.46, 146.46]. Both 
alcohol and placebo conditions predicted changes in SSRT (a path), X1 t(96) = 5.01, p < 
.001, 95%CI [40.53, 93.67], X2 t(96) = 6.98, p < .001, 95%CI [66.92, 120.07], X3 t(96) = 
8.14, p < .001, 95%CI [83.44, 135.58]. SSRT change however, did not predict ad libitum 
consumption (b path) t(95) = .66, p = .51, 95%CI [ -.56, 1.12]. The c’ pathway however, 
remained significant for alcohol conditions X2 t(95) = 2.37, p < .025, 95%CI [26.32, 298.45], 
X3 t(95) = 2.90, p < .025, 95%CI [66.67, 354.84] and placebo remaining non-significant X1 
t(95) = .66, p = .78 95%CI [-107.24, 141.68]. Indicating that SSRT change did not act as a 
mediator. See Figure 7 for mediation model.   
    
 
 
Figure 7: Mediation model examining change in stop-signal reaction time (SSRT) post-beverage as a 
mediator in the relationship between beverage condition and ad libitum consumption. Dummy 
variables computed comparing each experimental condition to pure control (X1 = placebo vs pure 
control, X2 = alcohol blind vs pure control, X3 = alcohol aware vs pure control). *p < .05, **p < .01, 
***p < .001 
 
Second, to assess if changes in craving as measured by the DAQ mediates the relationship 
between initial intoxication and subsequent consumption, a craving change score was 
calculated by subtracting the pre-beverage DAQ score from the post-beverage score. This 
new variable was used as the mediator in the analysis. Using the multicategorical function 
dummy variables were formed, comparing each condition to control (X1 = placebo vs pure 
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values remained the same (see Figure 7). Both alcohol and placebo condition predicted 
changes in craving (a path), X1 t(96) = 3.96, p < .001, 95%CI [4.39, 13.21], X2 t(96) = 5.06, 
p < .001, 95%CI [6.83, 15.65], X3 t(96) = 7.63, p < .001, 95%CI [12.54, 21.37]. Change in 
craving predicted ad libitum consumption (b path) t(95) = 1.99, p < .05, 95%CI [ .019, 
10.01]. The c’ pathway however, remained significant for alcohol conditions X2 t(95) = 2.14, 
p < .05, 95%CI [9.75, 254.64], X3 t(95) = 2.25, p < .05, 95%CI [18.31, 294.14]. Therefore, 
indicating that pharmacologically driven changes in craving partially mediate subsequent 
consumption. See Figure 8 for mediation model.      
 
 
Figure 8: Mediation model examining change in craving post-beverage as a mediator in the 
relationship between beverage condition and ad libitum consumption. Dummy variables computed 
comparing each experimental condition to pure control (X1 = placebo vs pure control, X2 = alcohol 
blind vs pure control, X3 = alcohol aware vs pure control). *p < .05, **p < .01, ***p < .001 
 
A final mediation model was conducted with the same parameters as above, this time to 
assess the role of AB as a potential mediator between beverage condition and ad libitum 
consumption. Pre-beverage AB was subtracted from post-beverage AB to provide a AB 
change score which was used as the mediator in the model. See previous mediation analysis 
for c path, as values remained the same. Only placebo predicted AB change (a path) X1 t(96) 
= 2.37, p < .025, 95%CI [ 23.05, 263.23]. AB change did not significantly predict ad libitum 
consumption (b path) t(95) = .05, p = .96, 95%CI [ -.19, .18]. The c’ path remained stable 






c’ X1, X2*, X3*
c X1, X2**, X3***
b*
t(95) = 4.30, p < .001, 95%CI [129.69, 352.47], but not placebo t(95) = .63, p = .53, 95%CI [-
77.63, 150.85] predicting ad libitum consumption. Indicating no mediation present. See 
figure 9 for mediation model. 
 
Figure 9: Mediation model examining change in AB post-beverage as a mediator in the relationship 
between beverage condition and ad libitum consumption. Dummy variables computed comparing 
each experimental condition to pure control (X1 = placebo vs pure control, X2 = alcohol blind vs pure 




The current study introduced a novel alcohol blind administration condition whereby 
participants were administered a dose of alcohol under deceptive conditions. Specifically, it 
combined this alcohol blind condition alongside widely-used administration techniques, 
which use the following two or three conditions: alcohol aware [alcohol consumed with 
participants’ knowledge], pure control [no alcohol supplied and participants are aware 
of this] and placebo [no alcohol consumed but participants are deceived). In so doing, this 
allowed for better isolation of alcohol’s pharmacological and anticipated effects, and for 
systematic exploration of their relative influence on inhibitory control, attentional bias, 
craving and alcohol seeking behaviours. Findings can be summarised as follows. In line with 
the first hypothesis, both the anticipatory and pharmacological effects of alcohol (placebo, 
alcohol aware, alcohol blind conditions) resulted in inhibitory control impairments and 
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alcohol blind conditions) also appeared to be associated with the greatest changes in 
inhibitory control and craving, in accordance with hypothesis two. The anticipatory but not 
the pharmacological effects of alcohol resulted in elevated alcohol-related attentional bias, in-
keeping with the prediction of hypothesis three and, in line with hypothesis four, Ad libitum 
consumption was heightened as a consequence of pharmacology, but not anticipation. 
Finally, as indicated in hypothesis five, increased ad libitum consumption associated with 
alcohol pharmacology was partially mediated by changes in craving, but not transient 
changes in inhibitory control as had also been predicted.  
  
In comparison with anticipated effects, the current findings identify alcohol’s 
pharmacological effects as the primary drivers of subsequent consumption. Specifically, 
elevated ad libitum consumption was only evident in the pharmacological conditions (in the 
alcohol aware and blind conditions), suggesting anticipation does not exert an influence on 
continued consumption. This is consistent with research findings which show heightened 
consumption following alcohol, but not placebo (Christiansen et al, 2013; McNeill et al., 
2021) and, to our knowledge, only one comparable study finding heightened consumption 
following placebo (Chirstiansen et al., 2017). Current findings from the alcohol blind 
beverage condition suggest that in the absence of anticipation, ad libitum consumption was 
akin to that observed in the traditional alcohol aware condition (where there is both the 
impact of pharmacology with anticipation). Moreover, pharmacological conditions displayed 
the greatest elevation in craving levels, with associations between the craving and activation 
in the dorsal striatum being well documented in the literature (see Volkow et al., 2016). 
Current findings, in this way, lend support to the notion that the maintenance of consumption 
is driven to a greater degree by alcohol’s pharmacological, as imposed to its anticipatory, 
effects.   
 
However, while our research  did not directly implicate the anticipated effects of 
alcohol in successive consumption, their influence on the alcohol-related cognitions could be 
ascertained. Specifically, anticipation was associated with significant increases in alcohol-
related attentional bias. This is consistent with the ‘satiation hypothesis’ suggesting that the 
absence of ‘reward’ satiation in striatum activates hypervigilance for alcohol-related stimuli, 
in an attempt to attain satiety (Monem & Fillmore, 2019). Specifically, findings by Monem 
and colleagues indicate that attentional bias for alcohol-related stimuli show dose-dependent 
decreases; however, the same pattern of decreases was not observed for other appetitive 
stimuli (ibid). These findings are also consistent with those suggestive of elevated attentional 
bias following placebo (McNeill et al., 2021). However, they are inconsistent with the notion 
that that elevated levels of craving should be associated with heightened attentional bias (e.g., 
Franken, 2003).  In this way, the current findings showed elevated attentional bias due to 
anticipation and, while this was correlated with changes in craving, the relationship was not 
observed in the other conditions. Furthermore, craving associated with anticipation was lower 
in anticipatory than in pharmacological conditions, neither of which appeared to exhibit 
pronounced attentional bias. Therefore, future research is required to disentangle the 
evidently nuanced relationship between craving and attentional bias, and the role anticipation 
may play.     
  
 In relation to inhibitory control and craving, the present findings do not appear to 
offer support for notion that anticipation exerts an additive effect on the impact of alcohol 
intoxication (e.g., Fillmore & Blackburn, 2002). Specifically, it appears that impaired 
inhibition and elevations in craving may be associated with alcohol’s anticipated effects; 
these changes were significantly more pronounced in relation to alcohol pharmacology. 
These findings were not unexpected and are observed in the literature (e.g., McNeill et al., 
2021). However, the administration of alcohol by deception (in the absence of anticipation – 
the alcohol blind condition) appears to shed new light on the relative contributions of 
anticipation and pharmacology where inhibitory control and craving are concerned. 
Importantly, the absence of significant differences in inhibition and craving between alcohol 
aware and blind conditions suggests that observed changes in inhibitory control and craving 
may be driven solely by the pharmacological effects of alcohol. In short, while anticipation 
alone may impact these important processes, according to our initial findings using this novel 
paradigm, alcohol intoxication appears to supersede any effects on these processes. Future 
research incorporating such alcohol blind designs is clearly required to explore this further.  
 
 Finally, although inhibitory control impairments were evident across all experimental 
manipulations, these did not appear to mediate ad libitum consumption, as previously 
suggested (Field et al., 2010; Jones et al., 2013). Rather, craving appeared to emerge as a 
more central influence on the initiation and maintenance of drinking, indicated by the partial 
mediatory association between initial intoxication and ad libitum consumption. This extends 
previous work indicating that transient impairments in inhibitory control are not directly 
associated with heightened consumption (McNeill et al., 2018; McNeill et al., 2021) and that 
implementation intentions and craving appear to supersede daily fluctuations in inhibitory 
control in predicting drinking episodes (Jones et al., 2018). Overall, there therefore appears to 
be a growing convergence of evidence to support the assertion that successive consumption 
may be driven primarily by the pharmacological effects of alcohol which are exerted via 
changes in craving. 
 
Several limitations must be borne in mind when considering current findings. First, 
increases in subjective intoxication were observed in the alcohol blind condition. While 
subjective intoxication did significantly increase from baseline, it did not vary from placebo 
and more importantly, it was significantly lower than in the alcohol aware condition. So, 
while one can be reasonably assured that participants in the alcohol blind condition were 
deceived regarding the presence of alcohol, it should be noted that anticipated effects cannot 
be ruled out entirely. In future, qualitative assessment of the degree to which participants 
were deceived concerning the presence of alcohol in the alcohol blind condition should be 
undertaken during debriefing, as this could afford an additional layer of certainty. Indeed, 
procedural signalling (Davies & Best, 1996) could mean that probing participants about 
alcohol-related craving may have intimated the presence of alcohol and it may therefore be 
possible to refine how participants are briefed about the research. In short, while the 
methodology developed may constitute a useful step forward in untangling the 
pharmacological from the anticipated effects of alcohol, there would appear to be room for 
further refinement. 
 
It should also be noted that, as with much of the laboratory-based alcohol research, 
the sample was student-centric. As such, future research is recommended in order to examine 
the extent to which the current findings generalise to wider populations where heavier, 
atypical drinking behaviour is less common (Borsari & Carey, 2001; Karam et al., 2007; 
Knight et al., 2002). Finally, it should be noted that the visual prob task produced low 
reliability levels. While this has also been found in other research in this area (e.g., Field & 
Christiansen, 2012), future research may benefit from the development of more rigorous 
cognitive tasks and more appropriate stimuli (Pennington et al., 2021) to verify that the 
current findings can be replicated using other methodological approaches. 
 
In conclusion, the current study incorporated a novel alcohol blind administration 
method (alongside alcohol aware, placebo and pure control conditions) in a first attempt to 
disentangle the pharmacological from the anticipated effects of alcohol on inhibitory control, 
attentional bias, and craving. Findings suggest that when compared with anticipation, 
pharmacology emerges as the primary driver of subsequent alcohol consumption. 
Specifically, the current research indicates that pharmacology induces the greatest cognitive 
changes and that the associated increases in consumption are mediated by changes in craving 
and not inhibitory control. Overall, it therefore appears prudent for future research to 
recognise the apparent dominant impact of alcohol’s pharmacological influences on craving, 
and we hope to have helped map out a new way of examining systematically the nuanced 
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